Pediatric medulloblastoma-update on prognosis factors / 中国医师杂志

ABSTRACT

Medulloblastoma is the most common malignant tumor of childhood.Over the past decade,progress in improving survival using conventional therapies has stalled.As advances in the molecular and genetic profiling of pediatric medulloblastoma evolve,associations with prognosis and treatment are found and research is directed at molecular therapies.The vast amount of genomic and molecular data generated over the last years encourages optimism that improved new molecular targets will improve outcomes.